HomeTTI • CVE
add
Thiogenesis Therapeutics Corp
Nakaraang pagsara
$0.64
Sakop ng taon
$0.60 - $1.06
Market cap
29.12M CAD
Average na Volume
10.20K
P/E ratio
-
Dividend yield
-
Primary exchange
CVE
Mga balita tungkol sa merkado
Mga Financial
Income Statement
Kita
Net na kita
(CAD) | Hun 2024info | Y/Y na pagbabago |
---|---|---|
Kita | — | — |
Gastos sa pagpapatakbo | 731.71K | -16.67% |
Net na kita | -651.32K | 25.17% |
Net profit margin | — | — |
Kita sa bawat share | — | — |
EBITDA | — | — |
Aktuwal na % ng binabayarang buwis | — | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
(CAD) | Hun 2024info | Y/Y na pagbabago |
---|---|---|
Cash at mga panandaliang investment | 4.97M | 7.06% |
Kabuuang asset | 5.06M | 7.78% |
Kabuuang sagutin | 308.45K | -11.83% |
Kabuuang equity | 4.76M | — |
Natitirang share | 45.50M | — |
Presyo para makapag-book | 6.40 | — |
Return on assets | -34.03% | — |
Return on capital | -36.23% | — |
Cash Flow
Net change in cash
(CAD) | Hun 2024info | Y/Y na pagbabago |
---|---|---|
Net na kita | -651.32K | 25.17% |
Cash mula sa mga operasyon | -551.12K | 19.56% |
Cash mula sa pag-invest | — | — |
Cash mula sa financing | 0.00 | — |
Net change in cash | -553.58K | 18.11% |
Malayang cash flow | -357.12K | 1.77% |
Tungkol
Itinatag
2018
Headquarters
Website